The Bacillus subtilis spoIIIA locus encodes eight proteins, SpoIIIAA to SpoIIIAH, which are expressed in the mother cell during endospore formation and which are essential for the activation of G in the forespore. Complementation studies indicated that this locus may be transcribed from two promoters, one promoter upstream from the first gene and possibly a second unidentified promoter within the locus. Fragments of the spoIIIA locus were expressed at an ectopic site to complement the sporulation-defective phenotype of a spoIIIAH deletion, and we determined that complementation required a fragment of DNA that extended into spoIIIAF. To confirm that there was a promoter located in spoIIIAF, we constructed transcriptional fusions to lacZ and found strong sporulation-induced promoter activity. Primer extension assays were used to determine the transcription start site, and point mutations introduced into the ؊10 and ؊35 regions of the promoter reduced its activity. This promoter is transcribed by E -RNA polymerase and is repressed by SpoIIID. Therefore, we concluded that the spoIIIA locus is transcribed from two promoters, one at the start of the locus (P1 spoIIIA ) and the other within the locus (P2 spoIIIA ). Based on Campbell integrations and reverse transcription-PCR analysis of the P2 spoIIIA region, we determined that P2 spoIIIA is sufficient for transcription of spoIIIAG and spoIIIAH. Inactivation of P2 spoIIIA blocked spore formation, indicating that P2 spoIIIA is essential for expression of spoIIIAG and spoIIIAH. The P2 spoIIIA activity is twice the P1 spoIIIA activity; therefore, larger amounts of SpoIIIAG and SpoIIIAH than of proteins encoded at the upstream end of the locus may be required.
In response to nutrient depletion, Bacillus subtilis can respond by differentiating into an endospore, which can remain dormant until nutrients become available to stimulate its germination. Soon after the onset of endospore formation, the cell divides into two morphologically distinct cells, the larger mother cell and the smaller forespore. During sporulation, 383 genes are expressed in the mother cell (8) , while 143 different genes are expressed in the forespore (23) . The cell type-specific patterns, as well as the temporal patterns of gene expression, are governed largely by the appearance and activation of four RNA polymerase sigma factors (for reviews, see references 9, 12, and 17). The activity of each of these sigma factors is tightly regulated for two purposes, thereby coupling the activation of gene expression to the completion of morphological landmarks and synchronizing the developmental programs of gene expression in each of the two cell types. For example, activation of G in the forespore requires E -directed gene expression in the mother cell.
Transcription of the spoIIIA locus by E is required for G activation (13, 15) . The spoIIIA locus, which is conserved throughout spore-forming bacteria, encodes eight proteins, SpoIIIAA to SpoIIIAH, each of which is required for G activation (15) . Seven of the eight products, SpoIIIAB to SpoIIIAH, are predicted to be membrane associated (4, 20, 22) ; SpoIIIAA shows homology to AAA-type ATPases, but the other seven proteins show homology only to their orthologs in other sporulating bacteria. SpoIIIAH interacts with the forespore-expressed protein SpoIIQ via the large extracellular Cterminal domains (1, 6, 18) . The two proteins make contact first at the septum between the mother cell and the forespore and then migrate with the mother cell membrane as the forespore is engulfed (1, 2). It is not known how this complex contributes to G activation or what roles the other spoIIIA-encoded proteins play. Transcription of the spoIIIA locus is initiated at a E -dependent promoter located immediately upstream of spoIIIAA (13) . Transcription from this promoter is repressed by the DNA binding protein SpoIIID (13) and possibly to a lesser extent by GerR (8) . Transcription from the gene immediately preceding the spoIIIA locus, yqhV, may also read into the spoIIIA locus since there is no obvious transcription terminator between the two genes. Since yqhV transcription is also E dependent and repressed by GerR, this may account for the effect of GerR on spoIIIA transcription (8) .
A number of operons found in both gram-positive and gramnegative bacteria are transcribed from more than one promoter. In some instances, these promoters are expressed under different conditions, and their activities are controlled by different RNA polymerase sigma factors or DNA binding proteins (3, 21) . The use of alternative promoters can also allow different levels of expression of different genes in the locus in response to different signals (16, 24) .
Two observations led us to suspect that a second promoter located within the spoIIIA locus may play a role in its expression. A transposon insertion into the extreme 5Ј end of spoIIIAA does not prevent expression of SpoIIIAH, as determined by Western blotting (1) . We also noted that when SpoIIIAH was directly expressed from the promoter located upstream from spoIIIAA (P1 spoIIIA ) at an ectopic locus, this construct did not complement the sporulation defect of a spoIIIAH mutant strain. Moreover, a second putative promoter within the locus had been proposed previously (19a) . Therefore, we began a search for the promoter responsible for spoIIIAH transcription.
We found a promoter (P2 spoIIIA ) that is located in spoIIIAF and is necessary and sufficient for expression of spoIIIAG and spoIIIAH.
MATERIALS AND METHODS
Bacterial strains and culture media. The strains and plasmids used in this study are shown in Tables 1 and 2 . Routine microbiological manipulations and procedures were carried out as described by Cutting and Harwood (5 
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concentrations of antibiotics used for selection in Luria broth (LB) and Difco sporulation medium (DSM) were as follows: 100 g/ml ampicillin, 5 g/ml chloramphenicol, 10 g/ml kanamycin, 100 g/ml spectinomycin, and 20 g/ml tetracycline. Cultures were grown in LB, and sporulation was induced by nutrient exhaustion in DSM. Competent cells were prepared and transformed using the Spizizen method (5) . To construct the plasmids used for complementation of the sporulation-defective phenotype of RL2045 (JH642 ⌬spoIIIAG) and RL2046 (JH642 ⌬spoIIIAH), fragments of DNA corresponding to spoIIIAH, spoIIIAGH, spoIIIAFGH and spoIIIAЈEFGH were amplified from JH642 chromosomal DNA, cloned into pDG1662 (11) digested with BamHI and EcoRI, and transformed into competent JH642, RL2045, and RL2046 with selection for chloramphenicol resistance and screening for spectinomycin sensitivity to confirm double crossovers into the amyE locus.
In order to more positively identify which region of DNA contained the putative promoter, we amplified the sections of DNA described above and cloned them into EcoRI-and BamHI-digested pDG1661 (11) , which contains a promoterless lacZ gene fused to the ribosome binding site of spoVG, and then we transformed the resulting plasmids into competent JH642, with selection for chloramphenicol resistance and screening for spectinomycin sensitivity to confirm double crossovers into the amyE locus. To compare the known spoIIIA operon promoter P1 spoIIIA (upstream of spoIIIAA) to P2 spoIIIA , we amplified DNA from position Ϫ246 to position 7 relative to the P1 spoIIIA transcription start site and cloned it into pDG1661 as described above.
Since we wanted to define the P2 spoIIIA promoter region more narrowly, we made sequential deletions from the 5Ј and 3Ј ends of the spoIIIAF gene. First, we kept the 5Ј end constant either at the second codon of spoIIIAF or at base 1016 of spoIIIAE, and the 3Ј end was moved inward from the last codon of spoIIIAF to the second codon of spoIIIAF in 200-bp intervals. DNA fragments resulting from the PCR amplifications were cloned into pDG1661 digested with EcoRI and BamHI and transformed into competent JH642 as described above. Once a suitable 3Ј end was established, as determined by ␤-galactosidase activity, we constructed and transformed pDG1661-based plasmids as described above that had DNA fragments with successive 100-bp deletions from the second codon of spoIIIAF.
The following double-crossover knockouts of potential P2 spoIIIA regulators were constructed in early and late stages of mother cell transcription: (i) E and regulators SpoIIID and GerR and (ii) K and a regulator GerE. Approximately 500 bp of 5Ј-and 3Ј-flanking DNA of each gene was amplified from chromosomal DNA and cloned into vectors designed for gene replacement. First gerR and sigE 5Ј homology regions were cloned into EcoRV-and EcoRI-digested pDG1726 (10) (spectinomycin), and then the 3Ј homology regions were cloned into the resulting plasmids with BamHI and SalI. The spoIIID 5Ј homology region was cloned into EcoRI-and BamHI-digested pDG784 (10) (kanamycin), and the 3Ј region was cloned into the resulting plasmid with PstI and SphI. Homology regions for sigK were cloned first into the EagI and BamHI sites of pDG1515 (10) (tetracycline) and then into the EcoRI and HindIII sites of the resulting plasmid. Each of the final plasmids was linearized with PstI or ScaI and transformed into competent CGB147 and CGB173 with selection for the appropriate antibiotic marker. Double crossovers were confirmed by PCR analysis. The gerE knockout was constructed by transforming competent CGB147 and CGB173 with chromosomal DNA isolated from laboratory stock strain AOB114 (MB24 gerE::kan) and selecting for kanamycin resistance.
To introduce point mutations into the Ϫ35 and Ϫ10 regions of P2 spoIIIA and into both potential alternative start codons for SpoIIIAG, we designed two complementary QuikChange oligonucleotides per desired mutation and performed QuikChange mutagenic PCR on pCG166 as described below. After sequencing to ensure the presence of the desired mutation, we subcloned (i) the previously defined promoter region into pDG1661 containing the separate Ϫ30 and Ϫ12/Ϫ11 mutations using EcoRI and BamHI and (ii) the entire spoIIIAFGH fragment containing the Ϫ12/Ϫ11 point mutations into both pDG1661 and pDG1662 using BamHI and EcoRI. The four resulting plasmids were transformed into competent JH642 (or RL2045 and RL2046 for pDG1662 derivatives) with selection for chloramphenicol resistance and screening for spectinomycin sensitivity to confirm double crossovers into the amyE gene.
Plasmids for Campbell integration into spoIIIAF, spoIIIAE, spoIIIAD, spoIIIAC, and spoIIIAB were constructed by amplifying each entire gene from chromosomal DNA along with its ribosome binding site and a few bases downstream of the stop codon and cloning the DNA into pMS38 digested with EcoRV and BamHI. The resulting plasmids were transformed into competent JH642 with selection for chloramphenicol resistance. The presence of single crossovers was confirmed by amplification of the ampicillin resistance gene on the pMS38 vector backbone from chromosomal DNA.
The promoter region of sspE, beginning 130 bp upstream of the Ϫ35 region and extending 5 bases past its ribosome binding site, was amplified from chromosomal DNA and cloned into pDG1661 digested with BamHI and HindIII. The plasmid was transformed into competent JH642 and CGB175 with selection for chloramphenicol resistance and screening for spectinomycin sensitivity to confirm double crossovers into the amyE gene.
In order to isolate a strain with the two base pair substitutions in the Ϫ10 region of P2 spoIIIA at the spoIIIA chromosomal locus, we cloned the spoIIIAFGH DNA fragment harboring the Ϫ12/Ϫ11 CA-to-GT P2 spoIIIA mutation from pCG170 into pDG784 (10) that had been cleaved with EcoRI and BamHI. In the second step, an approximately 500-bp fragment of DNA from the region immediately downstream of spoIIIAH was amplified and cloned into the pDG784 derivative between the PstI and SphI sites. The resulting plasmid was used to transform competent JH642 and CGB197 to kanamycin resistance. PCR amplification and DNA sequencing of the transformants were used to show that a double crossover resulted in replacement of the wild-type copy of P2 spoIIIA with the mutated P2 spoIIIA , resulting in strains CGB225 and CGB226, respectively. To test for complementation of the sporulation defect of CGB225, we isolated a derivative of CGB225 in which spoIIIAFGH was inserted at amyE.
Sporulation efficiency test. In order to determine the sporulation efficiency of B. subtilis strains, 5-ml cultures were incubated in DSM (supplemented with appropriate antibiotics for Campbell insertion strains) for approximately 48 h at 37°C (for 24 h at 37°C for point mutants). Aliquots of each culture were heated at 80°C for 10 min, serially diluted, and plated on LB agar (with appropriate antibiotics for Campbell strains). Unheated aliquots were also serially diluted and plated. Colonies were counted after 16 h of incubation at 37°C.
␤-Galactosidase assays. Overnight LB cultures (incubated at 30°C for point mutants and at 37°C for other strains) were diluted 1:100 in fresh DSM with 5 g/ml chloramphenicol (100 g/ml spectinomycin for CGB197 and its derivatives) and allowed to grow for 2 h at 37°C. Two 300-l aliquots were collected every 0.5 h until 6 h after the onset of sporulation (usually 8 to 8.5 h); the first aliquot was used to measure the optical density at 600 nm, while the second aliquot was spun down and the cell pellet was stored at Ϫ80°C until it was assayed for ␤-galactosidase activity (5).
RNA isolation. RNA was isolated from sporulating B. subtilis strains 4 h after the onset of sporulation using the Epicenter MasterPure RNA purification kit protocol (catalog no. MCR85102; Epicenter Biotechnologies), with the following modifications: 2 ml of RNAprotect bacterial reagent (catalog no. 76506; QIAGEN) was added to 1 ml of a culture and incubated 5 min at room temperature before cells were harvested. Six hundred microliters of tissue and cell lysis solution was added to the cell pellets, which were resuspended by vortexing. The cell suspension was placed in a tube containing lysing matrix B (catalog no. 6911-100; MP Biomedical) and then lysed in a Bio101 Fastprep FP120 machine (MP Biomedical) three times at speed 6 for 45 s. The glass beads were spun down by centrifugation at 16,100 ϫ g for 2 min, and 300 l of supernatant was transferred to a clean tube. Proteinase K was added as described in the kit protocol instructions, and the protocol was followed until the DNase I digestion step (step C). At this point, we incubated samples for 30 min after DNase I addition and repeated the entire step C to ensure that all DNA was removed. RNA was quantitated by spectrophotometric analysis at 260 nm.
Primer extension. Thirty picomoles of oligonucleotide primer lacZ-rev2 (Table 3) (100 pmol/l) was end labeled with [␥-32 P]ATP (Amersham Biosciences) according to the protocol for an Epicenter SequiTherm EXCEL II DNA sequencing kit (catalog no. SEM79020; Epicenter Biotechnologies), except that we incubated the reaction mixture for 60 min at 37°C and terminated the reaction by incubation at 70°C for 10 min. Labeled primer was purified over a MicroSpin G25 column (Amersham Biosciences) as described in the product manual. Six picomoles of purified labeled primer was added to 1.7 g of total RNA from CGB173, CGB193, and CGB194. cDNA synthesis was performed according to the Invitrogen ThermoScript reverse transcription (RT)-PCR system (catalog no. 11146-024; Invitrogen) protocol using a cDNA synthesis temperature of 55°C.
For sequencing, 1.5 pmol of purified labeled primer was used along with 50 fmol of pCG150 according to the Epicenter SequiTherm EXCEL II DNA sequencing kit (catalog no. SEM79020; Epicenter Biotechnologies) protocol, except that during cycle sequencing we added a 30-s annealing step at 55°C. Before electrophoresis on a 6% polyacrylamide gel with 6 M urea, loading buffer was added to all samples and the samples were heated at 90°C for 10 min. Samples were electrophoresed in 1ϫ Tris-borate-EDTA, (pH 8.3) at 65 W for 2 to 2.5 h or until the xylene cyanol had just run off the gel. The gel was dried and exposed overnight to an Amersham Biosciences phosphor screen.
Site-directed mutagenesis. Point mutations were introduced as described in the manual for a Stratagene QuikChange site-directed mutagenesis kit (catalog no. 200518; Stratagene) with the following PCR cycle parameters: one cycle of 95°C for 1 min, followed by 18 cycles of 95°C for 30 s, 55°C for 1 min, and 68°C for 7 min and a final extension step of 10 min at 68°C. One microliter of DpnI was added to each reaction mixture, and the tubes were incubated at 37°C for 1 to 2 h. Five to seven microliters of each reaction mixture was then transformed into One Shot Top10 chemically competent cells (Invitrogen) as described in the product manual. The entire transformation reaction mixture was plated on LB plates containing 100 g/ml ampicillin. Individual colonies were grown in liquid culture, and plasmid DNA was isolated (QIAGEN QIAprep spin miniprep kit) and sequenced to ensure that the desired mutation was present.
RT-PCR. RNA was prepared from wild-type B. subtilis JH642 at 4 h after the onset of sporulation as described above and used to make cDNA as described above, except that primer spoIIIAF-rev-BamHIB was used. PCR was then performed using primers spoIIIAF-for-EcoRIA and spoIIIAF-for-EcoRIC with spoIIIAF-rev-BamHIB and Platinum Taq high-fidelity DNA polymerase (Invitrogen) for 30 cycles according to the ThermoScript RT-PCR system protocol (Invitrogen). PCR products were electrophoresed on a 1.5% agarose gel. A negative control containing no reverse transcriptase was included for each primer set.
RESULTS
Second promoter within the spoIIIA locus. To search for the promoter that drives expression of spoIIIAG and spoIIIAH independent of the upstream spoIIIA genes, we tested the ability of fragments of the spoIIIA operon inserted into the chromosome at amyE to complement the sporulation-defective phenotypes of RL2045 and RL2046, which have in-frame nonpolar deletions of spoIIIAG and spoIIIAH, respectively. Only the fragments of DNA which contained DNA extending from spoIIIAF through spoIIIAH were able to complement mutations in spoIIIAG or spoIIIAH (Table 4) . Since a region in spoIIIAF was required for complementation of spoIIIAH and spoIIIAG mutants, we hypothesized that a promoter is located within spoIIIAF. To test this hypothesis, the same DNA fragments of the spoIIIA locus were transcriptionally fused to lacZ and inserted into the amyE locus. We then assayed ␤-galactosidase activity during growth and sporulation. In agreement with the complementation experiments, we found that only the fragments of DNA that extended into spoIIIAF were able to drive production of ␤-galactosidase (Fig. 1A) . In these strains, ␤-galactosidase activity began to accumulate about 1.5 h after the onset of sporulation, and maximum activity was reached approximately 2.5 h later (Fig. 1A) . This temporal pattern of ␤-galactosidase activity was similar to that observed when P1 spoIIIA was fused to lacZ (Fig. 1B) . However, the promoter within spoIIIAF, P2 spoIIIA , produced twice as much ␤-galactosidase activity as P1 spoIIIA (Fig. 1B) .
To more precisely locate P2 spoIIIA , we examined the effect of sequential deletions from the 3Ј end of spoIIIAF on ␤-galactosidase activity (Fig. 2) . A fragment that included the first 415 bp of spoIIIAF directed transcription of lacZ and produced as much ␤-galactosidase activity as the 800-bp fragment. Sequential deletions were then made from the 5Ј end of spoIIIAF, and we found that a fragment containing only about 200 bp of spoIIIAF directed expression of lacZ at the same level as the 800-bp fragment (Fig. 2) . Therefore, the new promoter P2 spoIIIA was located between bp 200 and 415 of spoIIIAF.
E directs transcription from P2 spoIIIA . SpoIIIAH accumulates in the mother cell (1), and transcriptional array data indicate that its transcription is dependent on the mother cellspecific sigma factor E (8, 19) . Therefore, we examined the effects of mutations in genes responsible for both early and late mother cell gene expression on the activity of P2 spoIIIA . The early transcriptional regulators GerR and SpoIIID and secondary sigma factor E and the late transcription factor GerE and secondary sigma factor K were inactivated by insertion of antibiotic cassettes. The effects of these mutations on expression of P1 spoIIIA -lacZ and P2 spoIIIA -lacZ were monitored during sporulation. Both promoters were found to be regulated by the same factors.
E was solely responsible for transcription of the promoters since very little ␤-galactosidase accumulated in the sigE mutant, and SpoIIID was responsible for repression of the promoters; in fact, in the absence of SpoIIID, twice as much ␤-galactosidase was produced from P2 spoIIIA (Fig. 3 and data not shown) . There were no significant effects on ␤-galactosidase activity when GerR, GerE, or K was absent (Fig. 3) .
We used primer extension to determine the transcription start site of P2 spoIIIA . RNA was harvested 4 h after the onset of sporulation from cultures of wild-type, ⌬sigE, and ⌬spoIIID strains harboring the P2 spoIIIA -lacZ fusion at amyE. We found that the 5Ј end of the major transcription product mapped to bp 289 of spoIIIAF (Fig. 4) . The effects on P2 spoIIIA transcription of the mutations in sigE, which encodes E , and spoIIID were the same as those seen in the ␤-galactosidase assays (Fig.  4) ; essentially, there was no transcript in the sigE deletion strain and there was about twice as much transcript in the spoIIID deletion strain.
Inspection of the sequence upstream from the putative P2 spoIIIA start point of transcription revealed the sequences 5ЈAAATACA and 5ЈCATATATT (Fig. 5) in the Ϫ35 and Ϫ10 regions, respectively, that are similar to the consensus sequences in the Ϫ35 and Ϫ10 regions of E -dependent promoters (7), especially in the most highly conserved sequence in the Ϫ35 region (ATA) and all of the Ϫ10 region. Since transcription from P2 spoIIIA was dependent on E ( Fig. 3 and 4) , we expected that the highly conserved Ϫ10 and Ϫ35 region sequences would play important roles in promoter activity if the 5Ј end of the transcript indicated in our primer extension assays represented the actual start point of transcription. Therefore, we examined the effects of point mutations in the conserved sequences. The critical T residue in the Ϫ35 region (position Ϫ30) was changed to the nonconsensus base C, and the CA nucleotide pair in the Ϫ10 region (positions Ϫ12 and Ϫ11) was mutated to the nonconsensus nucleotide pair GT (Fig. 5) . Both of these mutations caused complete inactivation of P2 spoIIIA (data not shown).
The effects of mutations in the Ϫ10 and Ϫ35 regions of P2 spoIIIA demonstrated that this promoter was responsible for the E -dependent expression of the lacZ fusions described above, but we also tested whether this promoter was responsible for the expression of spoIIIAG and spoIIIAH at the amyE locus in the complementation experiments described above. We inserted the spoIIIAFGH fragment containing the Ϫ10 point mutations into the amyE locus and tested its ability to complement the spoIIIAG and spoIIIAH deletion mutants. We found that the mutant allele did not complement the sporulation defect in these strains (Table 4) . Therefore, P2 spoIIIA is required for expression of spoIIIAG and spoIIIAH in these strains.
P1 spoIIIA plays no role in spoIIIAG and spoIIIAH expression. All of our results are consistent with the hypothesis that E directs transcription from the P2 spoIIIA promoter and that this transcription probably is sufficient for spoIIIAG and spoIIIAH expression. P2 spoIIIA is located within spoIIIAF; therefore, it seemed likely that transcription initiated at P1 spoIIIA , which is required for spoIIIAF expression, would continue through P2 spoIIIA and into spoIIIAG and spoIIIAH. We used RT-PCR to determine whether this read-through occurred. RNA was isolated from wild-type strain JH642 4 h after the onset of sporulation, and RT-PCR was performed for two regions near P2 spoIIIA : a 350-bp region that extended 180 bp upstream of P2 spoIIIA to 150 bp downstream and a 140-bp region immediately downstream of P2 spoIIIA . After 30 cycles, the PCR products were electrophoresed on a 1.5% agarose gel. We detected the 350-bp product indicative of the read-through transcript (Fig. 6A) . The 140-bp RT-PCR product that resulted from transcription from both P1 spoIIIA and P2 spoIIIA was much more abundant than the 350-bp product that represented transcription from only P1 spoIIIA (Fig. 6B) .
Although our complementation studies, in which we expressed spoIIIAG and spoIIIAH at an ectopic location, indicated that P2 spoIIIA was necessary and sufficient for the expression of spoIIIAG and spoIIIAH, the RT-PCR results showing that transcripts from P1 spoIIIA read into spoIIIAG raised the possibility, which was unlikely, that transcription originating from P1 spoIIIA of spoIIIAG and spoIIIAH at the spoIIIA locus may enhance their expression and thus affect sporulation. Therefore, we isolated strains with Campbell-type insertions that would separate spoIIIAG and spoIIIAH from P1 spoIIIA (Fig.  7A) . A strain harboring the insertion in spoIIIAF, CGB175, exhibited almost wild-type levels of sporulation (99% of the wild-type levels). We also examined the effect of this Campbell-type insertion on expression of a G -dependent sspE-lacZ fusion and found no effect on its expression, indicating that there were no subtle effects on G activation (data not shown). As a control for these experiments, we also isolated a strain with an insertion in spoIIIAE, which resulted in separation of P1 spoIIIA from spoIIIAF and downstream genes (Fig. 7B) . This insertion reduced sporulation to 0.05% of that seen with a wild-type strain, indicating that the inserted sequences blocked transcription. Evidently, transcripts from P1 spoIIIA read into spoIIIAG and spoIIIAH since they traverse P2 spoIIIA ; however, they are not necessary to support sporulation. We also used the Campbell insertion technique to search for other potential promoters in the spoIIIA locus, but strains bearing such insertions in spoIIIAD, spoIIIAC, and spoIIIAB were sporulation defective (the sporulation efficiencies were 0.03 to 0.07% of the wild-type sporulation efficiencies), indicating that there are no other promoters (data not shown). This, along with our previ- (Fig. 1A and B) , indicated that transcription of spoIIIAG and spoIIIAH from P2 spoIIIA alone is sufficient for sporulation. P2 spoIIIA is essential for sporulation. The results of complementation tests indicated that transcription of spoIIIAG and spoIIIAH from P2 spoIIIA is sufficient when these genes are located at the ectopic amyE locus. At the chromosomal spoIIIA locus, transcription of spoIIIAH from P1 spoIIIA is not essential (1), so we predicted that transcription of both spoIIIAG and spoIIIAH from P2 spoIIIA at the spoIIIA locus is essential for sporulation. Therefore, we isolated a strain (CGB225) containing two base pair substitutions at positions Ϫ12 and Ϫ11 of P2 spoIIIA within the spoIIIA locus. These mutations resulted in a sporulation-deficient phenotype (0.025 to 0.7% of the wildtype sporulation level) and also reduced the expression of a G -dependent sspE-lacZ fusion (CGB226) to levels that were less than 30% of the wild-type levels (data not shown). We noted that the mutations in P2 spoIIIA resulted in a change in the coding region of spoIIIAF by producing an alanine-to-glycine substitution in SpoIIIAF. However, this amino acid substitution was not responsible for the sporulation-defective phenotype since spore formation was complemented to wild-type levels by expression of spoIIIAG and spoIIIAH from the P2 spoIIIA promoter at amyE in strain CGB227, a derivative of CGB225.
DISCUSSION
Our results indicate that the spoIIIA locus, which encodes eight genes, is transcribed from two promoters, P1 spoIIIA , which is located at the start of the locus, and P2 spoIIIA , which is located within the open reading frame of spoIIIAF. P2 spoIIIA is required for transcription of spoIIIAG and spoIIIAH. RT-PCR analysis showed that transcripts from P1 spoIIIA probably read through spoIIIAG and spoIIIAH, but the P1 spoIIIA -dependent transcripts may not produce enough spoIIIAG and spoIIIAH FIG. 7 . Separation of spoIIIAG and spoIIIAH from P1 spoIIIA : models of the Campbell-type integration of plasmids into the spoIIIA locus. (A) Model in which a nonreplicating circular plasmid carrying spoIIIAF integrates into the spoIIIA locus by a single homologous recombination event. A horizontal arrow indicates that transcription from P1 spoIIIA proceeds uninterrupted through spoIIIAF, while spoIIIAG and spoIIIAH are transcribed from P2 spoIIIA . (B) Model in which a nonreplicating circular plasmid carrying spoIIIAE integrates into the spoIIIA locus by a single homologous recombination event. A horizontal arrow indicates that transcription from P1 spoIIIA is interrupted by plasmid sequences (wavy line) before entering spoIIIAF, resulting in a sporulation-defective phenotype. The intervening plasmid DNA is represented by a wavy line in both panels and is not to scale.
7188
products. This conclusion follows from our observations that P2 spoIIIA -lacZ was expressed at twice the levels of P1 spoIIIAlacZ (Fig. 1B) and that expression of a P1 spoIIIA -spoIIIAH fusion was not sufficient to complement the sporulation defect of a mutant spoIIIAH strain (Table 4) . Furthermore, expression of spoIIIAG and spoIIIAH from P2 spoIIIA is sufficient to support sporulation, since P2 spoIIIA -driven expression of spoIIIAG and spoIIIAH complements from an ectopic location (Table 4) , and an insertion physically separating spoIIIAG and spoIIIAH from P1 spoIIIA had no detectable effect on sporulation efficiency or on the timing of G activation (data not shown). Moreover, mutation of P2 spoIIIA at the spoIIIA locus caused a sporulation-defective phenotype that could be complemented by expression of spoIIIAG and spoIIIAH at the amyE locus.
There are many examples of complex operons containing more than one promoter in both gram-positive and gramnegative bacteria (3, 14, 16, 24) . However, the most common reason for having more than one promoter for an operon is to ensure its expression under different growth conditions or requirements. The promoters of these operons are usually recognized by different sigma factors or may require other types of different transcription factors for expression. Therefore, a potential explanation for the necessity of a second promoter within the spoIIIA locus could be that P1 spoIIIA and P2 spoIIIA are differentially regulated. However, this possibility is unlikely because transcription from both promoters appears to be directly dependent on E and the activities of both promoters are repressed by SpoIIID. We found at least two potential SpoIIID binding sites centered at position Ϫ22 relative to the P2 spoIIIA transcription start site (bp 301 of spoIIIAF) (Fig. 5) and at position 11 (bp 268 of spoIIIAF) (not shown). These conserved sequences and the elevated expression from P2 spoIIIA that we observed in the spoIIID mutant ( Fig. 3 and 4) are consistent with a model in which SpoIIID directly represses P2 spoIIIA activity, as is the case for P1 spoIIIA (8, 13) . Therefore, it is unlikely that the two promoters in the spoIIIA locus are differentially regulated; rather, it is likely that the primary purpose of P2 spoIIIA has to do only with increasing the expression of the last two genes of the locus.
Although the reason that a second promoter in the locus, P2 spoIIIA , is required is not entirely clear, this promoter may be a conserved feature within the spoIIIA locus of other spore formers (Fig. 5) . The hypothesis that the second promoter in the locus, P2 spoIIIA , is required because higher levels of SpoIIIAG and SpoIIIAH than of the upstream spoIIIA products are required for sporulation led us to speculate that SpoII-IAG and SpoIIIAH play different types of roles in sporulation than the other members of the locus. This idea is supported by topology predictions of SpoIIIAG and SpoIIIAH that show that these proteins are more similar to one another than to any other protein encoded by the spoIIIA locus (4, 20, 22) . SpoII-IAH is known to recruit other proteins involved in intercellular signaling to the septum separating the mother cell and forespore (6) . SpoIIIAH has also been postulated to help drive the engulfment of the forespore (2) . The SpoIIIA proteins encoded by upstream genes are also essential for spore formation and, like SpoIIIAH and SpoIIIAG, are required for activation of G (15) . However, these proteins, SpoIIIAA to SpoIIIAF, may act catalytically or at least at lower stoichiometries than SpoIIIAG and SpoIIIAH.
